Plunkett Research Online: QRxPharma Limited

QRXPHARMA LIMITED (QRXPY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

QRxPharma Limited is involved in the development and commercialization of biopharmaceutical products for pain management and central nervous system disorders, targeting the U.S. and European markets. It conducts its operations in Australia, with the main focus on MoxDuo (Morphine & Oxycodones) produ.....

QRxPharma Limited
Ticker: QRXPY
Exchange: PINX
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 61 294928021
Fax: 61 289200314
Address: 697 Burke Road
Suite 201
Melbourne, VIC 3124 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing

Legal Advisor:
$USD, In whole numbers,
except marked * or %
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: